## Abstract There has been accumulating evidence that CD4^+^CD25^+^ FoxP3 expressing regulatory T cells (Treg) are highly concentrated in tumors, thereby fostering an immune‐privileged microenvironment. Some studies have shown that T‐cell receptor (TCR) stimulation can convert conventional T cells
Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4+T cells
✍ Scribed by Kazue Kogina; Hirofumi Shoda; Yumi Yamaguchi; Nelson H. Tsuno; Koki Takahashi; Keishi Fujio; Kazuhiko Yamamoto
- Publisher
- Korean Society for Molecular and Cellular Biology
- Year
- 2009
- Tongue
- English
- Weight
- 375 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1016-8478
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
CD28 and CTLA-4 are opposing regulators of T cell activation, triggered by the two ligands CD80 and CD86. How these ligands promote either T cell activation via CD28 or inhibition via CTLA-4 is not understood. Using CD80 and CD86 molecules expressed on transfected cells, we have identified a major d
The immune system is a delicately balanced network of interacting cells. In recent years, the concept of immune regulation/suppression has been firmly established, and both natural and induced regulatory cells play vital roles in protection from autoimmune disease. Recent work has revealed the diver
## Abstract CD4 binds to MHC class II molecules and enhances T‐cell activation. The CD4‐related transmembrane protein LAG‐3 (lymphocyte activation gene‐3, CD223) binds to the same ligand but inhibits T‐cell proliferation. We have previously shown that LAG‐3 cell surface expression is tightly regula